Literature DB >> 3694619

Drug overdose--a hidden hazard of obesity.

J Cox1, N Penn, M Masood, A K Hancock, D Parker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3694619      PMCID： PMC1291097          DOI： 10.1177/014107688708001118

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics and metabolism of adriamycin in man.

Authors:  R S Benjamin; C E Riggs; N R Bachur
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

2.  Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

Authors:  R S Benjamin; P H Wiernik; N R Bachur
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

3.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

4.  Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia.

Authors:  D E Brenner; P H Wiernik; M Wesley; N R Bachur
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

5.  Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration.

Authors:  Y T Lee; K K Chan; P A Harris; J L Cohen
Journal:  Cancer       Date:  1980-05-01       Impact factor: 6.860
  5 in total
  3 in total

1.  Adipocytes impair leukemia treatment in mice.

Authors:  James W Behan; Jason P Yun; Marina P Proektor; Ehsan A Ehsanipour; Anna Arutyunyan; Ara S Moses; Vassilios I Avramis; Stan G Louie; Anna Butturini; Nora Heisterkamp; Steven D Mittelman
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 2.  Clinical pharmacokinetics of drugs in obesity. An update.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

3.  Dosing of thioTEPA for myeloablative therapy.

Authors:  D Przepiorka; T Madden; C Ippoliti; Z Estrov; M Dimopoulos
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.